|
GABPA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.024410E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.395600E-01 |
| Normal-vs-Stage2 |
4.180800E-01 |
| Normal-vs-Stage3 |
7.683500E-03 |
| Normal-vs-Stage4 |
4.50829999998348E-06 |
| Stage1-vs-Stage2 |
7.764800E-01 |
| Stage1-vs-Stage3 |
4.312500E-02 |
| Stage1-vs-Stage4 |
1.041410E-04 |
| Stage2-vs-Stage3 |
4.607200E-01 |
| Stage2-vs-Stage4 |
1.584790E-01 |
| Stage3-vs-Stage4 |
2.649200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.664100E-02 |
| Normal-vs-AfricanAmerican |
2.236300E-04 |
| Normal-vs-Asian |
7.944000E-01 |
| Caucasian-vs-AfricanAmerican |
1.857690E-02 |
| Caucasian-vs-Asian |
7.896000E-01 |
| AfricanAmerican-vs-Asian |
2.275800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.219200E-03 |
| Normal-vs-Female |
6.609700E-02 |
| Male-vs-Female |
5.282200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.063600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.082600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.537800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.581000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.895800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.382400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.972600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.473700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.317900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.544000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.391350E-01 |
| Normal-vs-Grade 2 |
9.806200E-01 |
| Normal-vs-Grade 3 |
5.92600000000054E-05 |
| Normal-vs-Grade 4 |
4.3613999967107E-08 |
| Grade 1-vs-Grade 2 |
4.024400E-01 |
| Grade 1-vs-Grade 3 |
4.988100E-04 |
| Grade 1-vs-Grade 4 |
2.00379999999445E-05 |
| Grade 2-vs-Grade 3 |
1.367390E-04 |
| Grade 2-vs-Grade 4 |
1.16479999978658E-07 |
| Grade 3-vs-Grade 4 |
1.274100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.146400E-01 |
| Normal-vs-ccB subtype |
3.433000E-04 |
| ccA subtype-vs-ccB subtype |
1.79765999999137E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.761700E-02 |
| Normal-vs-N1 |
5.556900E-03 |
| N0-vs-N1 |
2.912600E-01 |
|
|
